Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
172 hedge funds and large institutions have $1.05B invested in Intersect ENT, Inc in 2018 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 60 increasing their positions, 56 reducing their positions, and 13 closing their positions.
291% more call options, than puts
Call options by funds: $2.31M | Put options by funds: $590K
131% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 13
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
29% more capital invested
Capital invested by funds: $817M → $1.05B (+$236M)
10% more funds holding
Funds holding: 157 → 172 (+15)
7% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 56
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$46.5M |
| 2 |
HM
HealthCor Management
New York
|
+$17M |
| 3 |
FA
Friess Associates
Greenville,
Delaware
|
+$10.7M |
| 4 |
CCM
Cadian Capital Management
New York
|
+$9.23M |
| 5 |
Public Employees Retirement Association of Colorado
Denver,
Colorado
|
+$8.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$23.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$18.6M |
| 3 |
Jennison Associates
New York
|
-$13.2M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$11.9M |
| 5 |
Neuberger Berman Group
New York
|
-$7.15M |
XENT Hedge Fund Activity: Q1 2018 in Review
172 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q1 2018, worth a combined $1.05B — up 29% from $817M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new XENT positions and 13 closed out — a net gain of 17 holders — while 60 added to existing stakes and 56 trimmed.
The largest buyer was Invesco, adding an estimated $46.5M. The largest seller was Deerfield Management, cutting an estimated $23.2M.
- 172 institutional investors held Intersect ENT, Inc (XENT) as of Q1 2018, up from 157 in Q4 2017.
- Funds reported $1.05B of Intersect ENT, Inc stock for Q1 2018, up 29% quarter-over-quarter.
- 30 funds opened new Intersect ENT, Inc positions in Q1 2018 and 13 closed out, a net change of +17 holders.
- The largest Intersect ENT, Inc buyer in Q1 2018 was Invesco, an estimated $46.5M added.
- The largest Intersect ENT, Inc seller in Q1 2018 was Deerfield Management, an estimated $23.2M sold.
Based on aggregated 13F filings for Q1 2018.